Shannon joins Valeant Pharmaceuticals
By Adnews Staff
Valeant Pharmaceuticals of Laval, QC has appointed Arthur Shannon to the position of senior vice-president, and head of communications and investor relations. Shannon was most recently vice-president of global corporate affairs and European investor relations at Perrigo. Prior to that, he held a series of investor relations positions at Thomson Financial and Dynegy.
« Back Next »
Comments
blog comments powered by Disqus